Evidence map›Paper›PMID 25370038›Full record

ArticleEuropean journal of human genetics : EJHG2015

Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer.

Fadwa A Elsayed, C Marleen Kets, Dina Ruano, Brendy van den Akker, Arjen R Mensenkamp, Melanie Schrumpf, Maartje Nielsen, Juul T Wijnen, Carli M Tops, Marjolijn J Ligtenberg and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 3 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 3 syntheses or guidelines pooled it, 124 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Review
  8. Frontiers in oncology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Unraveling the impact of a germline heterozygousFrontiers in molecular biosciences · 2023
    Article
  17. Article
  18. POLE/POLD1 mutation and tumor immunotherapy.Journal of experimental & clinical cancer research : CR · 2022
    Review
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Fadwa A ElsayedDepartment of Pathology, LUMC, Leiden, The Netherlands.
C Marleen KetsDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Dina RuanoDepartment of Pathology, LUMC, Leiden, The Netherlands.
Brendy van den AkkerDepartment of Pathology, LUMC, Leiden, The Netherlands.
Arjen R MensenkampDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Melanie SchrumpfDepartment of Pathology, LUMC, Leiden, The Netherlands.
Maartje NielsenDepartment of Clinical Genetics, LUMC, Leiden, The Netherlands.
Juul T Wijnen1] Department of Clinical Genetics, LUMC, Leiden, The Netherlands [2] Department of Human Genetics, LUMC, Leiden, The Netherlands.
Carli M TopsDepartment of Clinical Genetics, LUMC, Leiden, The Netherlands.
Marjolijn J Ligtenberg1] Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands [2] Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Hans F A VasenDepartment of Gastroenterology, LUMC, Leiden, The Netherlands.
Frederik J HesDepartment of Clinical Genetics, LUMC, Leiden, The Netherlands.ORCID 0000000230250882
Hans MorreauDepartment of Pathology, LUMC, Leiden, The Netherlands.
Tom van WezelDepartment of Pathology, LUMC, Leiden, The Netherlands.ORCID 0000000157737730
Leiden University Medical Center · NLRadboud University Nijmegen · NL

Funding

Worldwide Cancer Research 10-0619
6 · The paper itself

Abstract

Germline variants affecting the exonuclease domains of POLE and POLD1 predispose to multiple colorectal adenomas and/or colorectal cancer (CRC). The aim of this study was to estimate the prevalence of previously described heterozygous germline variants POLE c.1270C>G, p.(Leu424Val) and POLD1 c.1433G>A, p.(Ser478Asn) in a Dutch series of unexplained familial, early onset CRC and polyposis index cases. We examined 1188 familial CRC and polyposis index patients for POLE p.(Leu424Val) and POLD1 p.(Ser478Asn) variants using competitive allele-specific PCR. In addition, protein expression of the POLE and DNA mismatch repair genes was studied by immunohistochemistry in tumours from POLE carriers. Somatic mutations were screened using semiconductor sequencing. We detected three index patients (0.25%) with a POLE p.(Leu424Val) variant. In one patient, the variant was found to be de-novo. Tumours from three patients from two families were microsatellite instable, and immunohistochemistry showed MSH6/MSH2 deficiency suggestive of Lynch syndrome. Somatic mutations but no germline MSH6 and MSH2 variants were subsequently found, and one tumour displayed a hypermutator phenotype. None of the 1188 patients carried the POLD1 p.(Ser478Asn) variant. POLE germline variant carriers are also associated with a microsatellite instable CRC. POLE DNA analysis now seems warranted in microsatellite instable CRC, especially in the absence of a causative DNA mismatch repair gene germline variant.

Indexed as

AdolescentAdultBrain NeoplasmsColorectal NeoplasmsDNA-Binding ProteinsDNA Mismatch RepairDNA Polymerase IIDNA Polymerase IIIFemaleGerm-Line MutationHumansMaleMiddle AgedMutS Homolog 2 ProteinNeoplastic Syndromes, HereditaryPoly-ADP-Ribose Binding ProteinsDNA-Binding ProteinsDNA Polymerase IIDNA Polymerase IIIG-T mismatch-binding proteinMSH2 protein, humanMutS Homolog 2 ProteinPOLD1 protein, humanPOLE protein, humanPoly-ADP-Ribose Binding Proteins

Identifiers

PMID25370038
PMCPMC4351893
OpenAlexW2077109689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.